A small molecule primes embryonic stem cells for differentiation

Cell Stem Cell. 2009 May 8;4(5):416-26. doi: 10.1016/j.stem.2009.04.001.

Abstract

Embryonic stem cells (ESCs) are an attractive source of cells for disease modeling in vitro and may eventually provide access to cells/tissues for the treatment of many degenerative diseases. However, applications of ESC-derived cell types are largely hindered by the lack of highly efficient methods for lineage-specific differentiation. Using a high-content screen, we have identified a small molecule, named stauprimide, that increases the efficiency of the directed differentiation of mouse and human ESCs in synergy with defined extracellular signaling cues. Affinity-based methods revealed that stauprimide interacts with NME2 and inhibits its nuclear localization. This, in turn, leads to downregulation of c-Myc, a key regulator of the pluripotent state. Thus, our findings identify a chemical tool that primes ESCs for efficient differentiation through a mechanism that affects c-Myc expression, and this study points to an important role for NME2 in ESC self-renewal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation* / drug effects
  • Chromatin Immunoprecipitation
  • Down-Regulation
  • Embryo, Mammalian / cytology
  • Embryo, Mammalian / metabolism
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism
  • Endoderm / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Genes, myc
  • Humans
  • Mice
  • NM23 Nucleoside Diphosphate Kinases / antagonists & inhibitors
  • NM23 Nucleoside Diphosphate Kinases / genetics
  • NM23 Nucleoside Diphosphate Kinases / metabolism
  • Staurosporine / analogs & derivatives*
  • Staurosporine / pharmacology

Substances

  • Enzyme Inhibitors
  • NM23 Nucleoside Diphosphate Kinases
  • staurprimide
  • Staurosporine